Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: A belgian case series

Inflammatory Bowel Diseases

Volumn 16, Issue 2, 2010, Pages 243-249

  Ferrante, Marc ^a   D'Haens, Geert ^b   Dewit, Olivier ^c   Baert, Filip ^d   Holvoet, Jan ^d   Geboes, Karel ^a   De Hertogh, Gert ^a   Van Assche, Gert ^a   Vermeire, Séverine ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b IMELDA HOSPITAL   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d Heilig Hartziekenhuis ^*  (Belgium)

Author keywords

Crohn's disease; Infliximab; IPAA; Refractory pouchitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BELGIUM; BLEEDING; CLINICAL ARTICLE; COLON RESECTION; CROHN DISEASE; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; ILEITIS; ILEOSTOMY; INTESTINE FISTULA; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BELGIUM; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POUCHITIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73949155883     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21037     Document Type: Article

References (20)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
2. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444-1451.
3. Melville DM, Ritchie JK, Nicholls RJ, et al. Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience. Gut. 1994;35:1076-1080.
4. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222: 120-127.
5. Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20-28.
6. Sandborn WJ, Pardi DS. Clinical management of pouchitis. Gastroenterology. 2004;127:1809-1814.
7. Shen B, Fazio VW, Remzi FH, Lashner BA. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol. 2005;100: 2796-2807.
8. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549.
9. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340: 1398-1405.
10. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350: 876-885.
11. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337:1029-1035.
12. Patel RT, Bain I, Youngs D, et al. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum. 1995;38: 831-837.
13. Arnott ID, McDonald D, Williams A, et al. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther. 2001;15:1639-1646.
14. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759-764.
15. Colombel JF, Ricart E, Loftus EV Jr, et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol. 2003;98:2239-2244.
16. Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther. 2003;17:1263-1271.
17. Shen B, Remzi FH, Lavery IC, et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther. 2009;29:519-526.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
19. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
20. Shen B, Achkar JP, Connor JT, et al. Modified pouchitis disease activity index - a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003;46:748-753.